Cargando…
Is there an interaction between dexamethasone and sugammadex in real clinical conditions? A randomized controlled trial in patients undergoing laparoscopic cholecystectomy
BACKGROUND AND AIMS: There is evidence that sugammadex can encapsulate other substances except rocuronium, such as dexamethasone. The aim of this study was to investigate the possible clinical interaction between dexamethasone and sugammadex, in patients undergoing laparoscopic cholecystectomy. MATE...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6598587/ https://www.ncbi.nlm.nih.gov/pubmed/31303711 http://dx.doi.org/10.4103/joacp.JOACP_42_17 |
_version_ | 1783430804367474688 |
---|---|
author | Batistaki, Chrysanthi Pandazi, Aggeliki Kyttari, Aikaterini Kaminiotis, Evangelia Kostopanagiotou, Georgia |
author_facet | Batistaki, Chrysanthi Pandazi, Aggeliki Kyttari, Aikaterini Kaminiotis, Evangelia Kostopanagiotou, Georgia |
author_sort | Batistaki, Chrysanthi |
collection | PubMed |
description | BACKGROUND AND AIMS: There is evidence that sugammadex can encapsulate other substances except rocuronium, such as dexamethasone. The aim of this study was to investigate the possible clinical interaction between dexamethasone and sugammadex, in patients undergoing laparoscopic cholecystectomy. MATERIAL AND METHODS: This was a randomized, double-blind controlled trial, performed in patients aged 18–75 years, American Society of Anesthesiologists (ASA) I–III, who underwent a laparoscopic cholecystectomy under deep neuromuscular blockade with rocuronium. Patients received 5 mg of dexamethasone or placebo (N/S 0.9%) during induction of anesthesia. Sugammadex 4 mg/kg was administered at the end of surgery at post-tetanic count 1–2. The outcome measures assessed were the time from sugammadex administration until train-of-four (TOF) 0.9, and until patient's extubation, postoperative pain (measured by numeric rating scale 0–10), nausea and vomiting, as well as rescue analgesics and antiemetics required during the first 24 hours postoperatively. The total dose of rocuronium required in both groups was also recorded. RESULTS: Overall, 44 patients were studied. No difference was detected regarding the demographic and surgical characteristics of patients. The time from sugammadex administration until TOF 0.9 and until patients' extubation did not differ significantly between the groups (P = 0.21 and 0.17). Operating conditions, pain scores, nausea/vomiting, and rescue analgesics and antiemetics during the first 24 hours postoperatively, did not differ between the groups. The total dose of rocuronium, however, was significantly more in patients who received dexamethasone (P = 0.01). CONCLUSION: No significant clinical interaction was revealed between dexamethasone and sugammadex during reversal of deep neuromuscular blockade in patients undergoing laparoscopic cholecystectomy. |
format | Online Article Text |
id | pubmed-6598587 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-65985872019-07-12 Is there an interaction between dexamethasone and sugammadex in real clinical conditions? A randomized controlled trial in patients undergoing laparoscopic cholecystectomy Batistaki, Chrysanthi Pandazi, Aggeliki Kyttari, Aikaterini Kaminiotis, Evangelia Kostopanagiotou, Georgia J Anaesthesiol Clin Pharmacol Original Article BACKGROUND AND AIMS: There is evidence that sugammadex can encapsulate other substances except rocuronium, such as dexamethasone. The aim of this study was to investigate the possible clinical interaction between dexamethasone and sugammadex, in patients undergoing laparoscopic cholecystectomy. MATERIAL AND METHODS: This was a randomized, double-blind controlled trial, performed in patients aged 18–75 years, American Society of Anesthesiologists (ASA) I–III, who underwent a laparoscopic cholecystectomy under deep neuromuscular blockade with rocuronium. Patients received 5 mg of dexamethasone or placebo (N/S 0.9%) during induction of anesthesia. Sugammadex 4 mg/kg was administered at the end of surgery at post-tetanic count 1–2. The outcome measures assessed were the time from sugammadex administration until train-of-four (TOF) 0.9, and until patient's extubation, postoperative pain (measured by numeric rating scale 0–10), nausea and vomiting, as well as rescue analgesics and antiemetics required during the first 24 hours postoperatively. The total dose of rocuronium required in both groups was also recorded. RESULTS: Overall, 44 patients were studied. No difference was detected regarding the demographic and surgical characteristics of patients. The time from sugammadex administration until TOF 0.9 and until patients' extubation did not differ significantly between the groups (P = 0.21 and 0.17). Operating conditions, pain scores, nausea/vomiting, and rescue analgesics and antiemetics during the first 24 hours postoperatively, did not differ between the groups. The total dose of rocuronium, however, was significantly more in patients who received dexamethasone (P = 0.01). CONCLUSION: No significant clinical interaction was revealed between dexamethasone and sugammadex during reversal of deep neuromuscular blockade in patients undergoing laparoscopic cholecystectomy. Wolters Kluwer - Medknow 2019 /pmc/articles/PMC6598587/ /pubmed/31303711 http://dx.doi.org/10.4103/joacp.JOACP_42_17 Text en Copyright: © 2019 Journal of Anaesthesiology Clinical Pharmacology http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Batistaki, Chrysanthi Pandazi, Aggeliki Kyttari, Aikaterini Kaminiotis, Evangelia Kostopanagiotou, Georgia Is there an interaction between dexamethasone and sugammadex in real clinical conditions? A randomized controlled trial in patients undergoing laparoscopic cholecystectomy |
title | Is there an interaction between dexamethasone and sugammadex in real clinical conditions? A randomized controlled trial in patients undergoing laparoscopic cholecystectomy |
title_full | Is there an interaction between dexamethasone and sugammadex in real clinical conditions? A randomized controlled trial in patients undergoing laparoscopic cholecystectomy |
title_fullStr | Is there an interaction between dexamethasone and sugammadex in real clinical conditions? A randomized controlled trial in patients undergoing laparoscopic cholecystectomy |
title_full_unstemmed | Is there an interaction between dexamethasone and sugammadex in real clinical conditions? A randomized controlled trial in patients undergoing laparoscopic cholecystectomy |
title_short | Is there an interaction between dexamethasone and sugammadex in real clinical conditions? A randomized controlled trial in patients undergoing laparoscopic cholecystectomy |
title_sort | is there an interaction between dexamethasone and sugammadex in real clinical conditions? a randomized controlled trial in patients undergoing laparoscopic cholecystectomy |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6598587/ https://www.ncbi.nlm.nih.gov/pubmed/31303711 http://dx.doi.org/10.4103/joacp.JOACP_42_17 |
work_keys_str_mv | AT batistakichrysanthi isthereaninteractionbetweendexamethasoneandsugammadexinrealclinicalconditionsarandomizedcontrolledtrialinpatientsundergoinglaparoscopiccholecystectomy AT pandaziaggeliki isthereaninteractionbetweendexamethasoneandsugammadexinrealclinicalconditionsarandomizedcontrolledtrialinpatientsundergoinglaparoscopiccholecystectomy AT kyttariaikaterini isthereaninteractionbetweendexamethasoneandsugammadexinrealclinicalconditionsarandomizedcontrolledtrialinpatientsundergoinglaparoscopiccholecystectomy AT kaminiotisevangelia isthereaninteractionbetweendexamethasoneandsugammadexinrealclinicalconditionsarandomizedcontrolledtrialinpatientsundergoinglaparoscopiccholecystectomy AT kostopanagiotougeorgia isthereaninteractionbetweendexamethasoneandsugammadexinrealclinicalconditionsarandomizedcontrolledtrialinpatientsundergoinglaparoscopiccholecystectomy |